MarleenKokLab
@lab_kok
Followers
2K
Following
2K
Statuses
687
medical oncologist, breast cancer immunotherapy investigator, mother, PI and associate prof at NKI, happy in Amsterdam
Amsterdam
Joined June 2020
@PTarantinoMD @DrHBurstein @SABCSSanAntonio @DFCI_BreastOnc #Halgorithm by Hal Burstein🤣🤣🤣🤣 Best algorithm but also best joke
0
1
2
Excited to present 🎤 first data #SABCS24 from TONIC2. Follow-up from Are immune induction with dox or cisplatin indeed benefiting pts? @VeerleGeurts at P1-7-30 and new data on acquired resist🔬 to aPD1 at PS17-09 @NKI_nl @OncoAlert @NatureMedicine
1
22
70
Recent Nature paper on phase of menstrual cycle at start of breast cancer chemo suggests that this can affect chemo-sensitivity. More research needed on how this can result in cycle-driven-chemo-start. 💊💉Congrats @vanRheenen_Lab @NKI_nl
2
5
34
0
0
2
@AACR @UPMCHillmanCC @SABCSSanAntonio Congrats @oesterreichs! So well-deserved especially for all your research and effort for lobular BC pts @elbcc
0
0
4
This is well-deserved! Congrats @deVisserKarin 🥳🥳. She was one of the first scientists recognizing the importance of immune cells in breast tumors. Thanks to key leaders like Karin we now start doing trials specific for BC with high TILs #OPTImal study @NKI_nl @TILsWorkGroup
🎉 Congratulations to @deVisserKarin on receiving the prestigious 2025 Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award! Karin’s groundbreaking work is internationally recognized ➡️
2
2
16
Fantastic PhD program at amazing institution @NKI_nl 👇
📢 Applications for the NKI PhD program open from Jan 1 - Feb 28. Join our international research community in Amsterdam, working in cancer biology, AI research & life sciences with leading scientists and top facilities #PhD #CancerResearch More info:
0
3
15
RT @MarjoleinMoor: Mensen die naar ons land vluchten voor hun leven, voor de toorn van kwaadaardige regimes die we bestrijden bijvoorbeeld,…
0
297
0
Stellar line up of speakers and spot on discussions and clinical cases! In the beautiful town of Padua🇮🇹 #AIBCC24 with @MOliveira_MD @vitti10 @prat_aleix @hoperugo and many others!
One of the unmissable meeting of the year, over the past 20 years! #AIBCC24 Now on stage @lab_kok on Immune system and #BreastCancer
@valeguarneri @prat_aleix @vitti10 @GaiaGriguolo @FedeMiglietta
0
1
22
On my way to one of the best conferences on translational cancer research! #MAP24 🚆🚆💚💚
📣 Register now for MAP 2024, 16-18 Oct, London. Join us for sessions on immune cells in SCLC, anti-tumour immunogenicity, endocrine resistance in breast cancer, FAT1 and the Hippo pathway, and more. #MAP2024 🔗
0
1
28
This will be amazing session #SABCS24 with stellar speakers and immune biomarkers inc TILs making their way to the clinic!
State of the Art: The Winding Road of Immune Biomarkers in Early Breast Cancer— Roberto Salgado, Justin Balko, and Priyanka Sharma will address this topic in this special session at #SABCS24 (December 10-13). Learn more: @BalkoLab @psharmalab
0
0
18
Thanks @ACIR_org for putting our work on neoadjuvant immunotherapy for TNBC in the spotlight @riannerolfes @Manon_deGraaf @LambrechtsDlab @NatureMedicine
In an adaptive, window-of-opportunity phase II neoadjuvant trial in early breast cancer, Nederlof and Isaeva et al. report that 4 weeks of anti-PD-1 or anti-PD-1 + anti-CTLA-4 showed immune activation in 53% and 60% of [...] @NKI_nl @lab_kok
1
2
10
RT @TurajlicLab: Applications for the Clinical PhD programme at @TheCrick are open including opportunities in our lab #CancerEvolution #Im…
0
3
0
@RoisinMConnolly @NKI_nl @TILsWorkGroup @NatureMedicine @RoussosTorres Congrats with this important paper @RoisinMConnolly
0
0
0